Community-acquired Pneumonia, Dyspnea
Conditions
Keywords
Community-acquired pneumonia, Diagnosis, Emergency medicine, Chest CT-scan
Brief summary
Primary objective : to estimate impact of CT-scan on diagnostic for emergency department (ED) patients with suspected Community-acquired Pneumonia (CAP). Secondary objective: to estimate impact of CT-scan on treatment (antimicrobial therapy) and site of care for ED patients with suspected CAP.
Detailed description
Rational: Community-acquired pneumonia (CAP) is a frequent infectious disorder in patients visiting the ED. CAP is responsible for high morbidity and associated-mortality is increasing in Western countries. CAP corresponds to invasion of the lung by pathogens. Diagnosis depends on clinical and X-ray assessment. However, these signs and symptoms are poorly specific and are often lacking. As prognosis depends on precocious and fitted antimicrobial treatment, making CAP diagnosis in a short time span (4-8 hours) is mandatory. Preliminary studies suggest that chest CT-scan could over-performed X-ray for diagnosis of CAP. Consensus conferences suggest the use of CT-scan in patients with uncertain diagnosis and unusual presentation and outcome. Because CT-scan is currently easily available, its use in a first intent is questionable for ED patients with suspected CAP. Primary objective: to estimate impact of CT-scan on diagnostic for ED patients with suspected CAP. Secondary objective: to estimate impact of CT-scan on treatment (antimicrobial therapy) and site of care for ED patients with suspected CAP. Prospective multicenter study to measure chest CT-scan impact. 350 patients visiting the ED of 4 inner tertiary teaching hospitals in Paris, France, with suspected CAP. Management: Patients will be managed according to current guidelines, including conventional chest X-ray. Evaluation criteria. Attending ED physicians will implement pre- and post-test proforma for diagnosis (CAP) level of certainty, treatment (antimicrobial agents), site of care, before and after chest CT-scan. Comparison of ED physician's answers before/after CT-scan. Patients will be followed until day 28. An adjudication committee (1 pneumologist, 1 infectiologist, 1 radiologist)will review patients' data for gold standard diagnosis. Statistical considerations: The investigators hypothesize that chest CT-scan wil modify diagnosis certainty in 20%. This implies that 300 participants should be enrolled to allow assessment of changes in 15 % et 25 %. Undue changes will be calculated a posteriori when diagnosis gold standard will be established by adjudication committee. Anticipated results: Chest CT-scan should improve diagnosis certainty, treatment and site-of-care in patients visiting the ED with suspected CAP. If this is observed in at least 20%, the investigators will measure impact of chest CT-scan in a prospective randomized interventional study.
Interventions
Patients with a suspicion of acquired pneumonia visiting the emergency department will do a chest CT-scan
Sponsors
Study design
Eligibility
Inclusion criteria
* Patient above 18 years of age * Patient with a presumptive diagnosis of CAP according to attending ED physician * Patient experiencing at least one systemic sign (T°\>38°C or \< 36°C, HR\>90/min, RR\>20/min) * Patient experiencing one respiratory sign (cough, lateral chest pain, localized crackles, dyspnea) that recently appeared * Patient with a prior medical examination, the results have been or will be communicated * Patient gave written informed consent or in cases of emergency parent/ support person who gave written informed consent if he/she is present on the day of inclusion
Exclusion criteria
* Pregnancy * Patient with shock * Patient with respiratory distress and immune suppression * Patient with other criteria for immediate ICU referral to ICU * Patient with living conditions making it impossible to follow 28 days * Patient not affiliated with a social security system
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Chest CT-scan | in 28 days | Percentage of diagnoses modified by chest CT-scan. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Treatments changes | in 28 days | Percentage of treatments changes (antimicrobial therapy) modified by chest CT-scan |
| Changes of site-of-care | in 28 days | Percentage of site-of-care (admission/non admission) modified by chest CT-scan |
| Identification of viral and bacterial agents | at day of inclusion (day 1) | Identification of viral and bacterial agents from nasal and pharyngeal swabs |
| Markers of infection in the blood | at day of inclusion (day 1) | Determination of markers of infection in the blood |
| Markers of infection and markers of inflammation in urine | at day of inclusion (day 1) | Determination of markers of infection and of inflammation in urine |
Countries
France